SANUWAVE Health, Inc. SNWV R2KPHARMA

Q: What is the current share price of SANUWAVE Health, Inc. (SNWV)?

As of 2026-10-23 16:27 PDT, SANUWAVE Health, Inc. (SNWV) trades at $5.22 on NasdaqGM. Its 52-week range is $4.00 to $45.00.

Q: What is the market capitalisation of SNWV?

SANUWAVE Health, Inc. (SNWV) has a market capitalisation of $44.90M on NasdaqGM.

Q: What is the P/E ratio of SNWV?

SNWV trades at a trailing price-to-earnings (P/E) ratio of 6.44. The industry average P/E is 25.45. Its price-to-book (P/B) ratio is 14.04.

Q: Is SNWV a good stock to buy?

This page provides a data-driven analysis of SANUWAVE Health, Inc. (SNWV), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Healthcare · Medical Devices · United States

https://sanuwave.com

Company Profile ↓

$5.22

-86.91% 1Y

Mkt Cap$44.90M

P/E6.44

P/B14.04

52W High$45.00

52W Low$4.00

Book Value$0.32

EPS (TTM)$0.81

Company Overview

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Why Investors Should Care

Healthy Capital Returns

Return on capital employed stands at 25.4%.

Steady Revenue Expansion

Revenue has grown at a 31.4% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 6.4, below the sector median of 25.4.

Healthy Margins

Maintains a net profit margin of 34.7%.

Recent Developments

Dec 2025 Revenue of $44.05M (+36.3% YoY); net profit $11.81M.
Trailing 12 Months Year-on-year growth — revenue -3.1%.
5-Year Trend Long-term compounding — revenue CAGR 31.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	31.45%
1 Year:	-3.10%

Stock Price Performance

1 Year:	-86.91%
6 Months:	-72.09%
3 Months:	-14.43%
1 Month:	+7.63%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed

52-Week Range 3% of range

$4.00 $45.00

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMABelow
RSI (14)52.14 · Neutral

Price Performance

1M+7.63%

3M-14.43%

6M-72.09%

1Y-86.91%

Valuation vs Sector

P/E of 6.44 is below the sector median of 25.45 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Healthy ROCE of 25.4%.
Excellent profit margin of 34.7%.
Compounding revenue at 31.4% over 5 years.

CONS

Trading 88.4% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

6.44

Industry PE

25.45

Forward P/E

-522.00

PEG Ratio

Book Value

$0.32

Price to Book

14.04

P/S

0.89

EV/EBITDA

11.84

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

31.45%

Profit 5Y

Revenue (YoY)

-3.10%

Earnings (YoY)

Profitability & Returns

ROCE

25.36%

ROE

ROA

5.51%

Profit Margin

34.66%

Op Margin

-2.88%

Gross Margin

76.33%

EPS (Latest Qtr)

$-0.08

EPS (TTM)

$0.81

Balance Sheet & Liquidity

Debt/Equity

7.43

Quick Ratio

0.83

Current Ratio

1.28

Debt

$20.71M

Total Assets

$36.60M

Current Assets

Working Capital

Ownership

Promoter Holding

1.30%

Chg in Prom Hold

-0.00%

FII / Inst Holding

37.33%

Chg in FII Hold

-0.00%

Financial Snapshot

Enterprise Value

$44.90M

Total Revenue (TTM)

$44.02M

EBITDA

$4.26M

Free Cash Flow

$-2.83M

Operating Cash Flow

$5.22M

Shares Outstanding

8.60M

Gross Margin

76.33%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	SNWV SANUWAVE Health, Inc. R2KPHARMA	5.22	6.44	$44.90M	0.00%	25.36%	-	31.45%	-
2	LLY Eli Lilly and Company SPXR3KPHARMA	1,273.46	42.83	$1.14T	0.60%	-	102.29%	7.20%	11.41%
3	JNJ Johnson & Johnson SPXR3KPHARMA	263.81	30.60	$635.76B	1.98%	14.88%	25.74%	2.43%	4.76%
4	ABBV AbbVie Inc. SPXR3KPHARMA	285.64	80.69	$504.76B	2.54%	10.47%	-129.24%	1.75%	-29.06%
5	UNH UnitedHealth Group Incorporated SPXR3KPHARMA	418.09	26.85	$375.28B	2.47%	9.74%	14.15%	10.40%	5.43%
6	MRK Merck & Co., Inc. SPXR3KPHARMA	145.27	116.22	$358.41B	2.31%	-	6.96%	5.64%	10.01%
7	NVS Novartis AG PHARMA	151.12	22.83	$287.24B	3.36%	21.09%	30.35%	9.25%	26.22%
8	AZN AstraZeneca PLC NDXPHARMA	171.49	25.63	$265.96B	2.00%	15.97%	21.96%	9.82%	45.96%
9	TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA	673.82	36.30	$249.14B	0.29%	8.14%	13.51%	8.81%	12.95%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Jun 2013	Sep 2013	Mar 2014	Jun 2014	Sep 2014	Mar 2015	Jun 2015	Sep 2015	Mar 2016	Jun 2016	Sep 2016	Mar 2017	Jun 2017	Sep 2017	Mar 2018	Jun 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	197.64K	149.00K	83.00K	1.37M	1.86M	2.63M	3.73M	2.85M	3.54M	3.92M	3.49M	4.41M	4.82M	5.68M	7.08M	9.29M	9.29M	10.15M	11.42M	-	-
Gross Profit	136.83K	118.95K	126.76K	174.72K	159.41K	151.63K	164.20K	104.85K	196.14K	125.42K	156.97K	-	-	99.90K	178.81K	286.57K	412.19K	84.11K	131.09K	74.72K	19.00K	4.00K	765.00K	1.06M	1.86M	2.17M	2.31M	2.79M	3.01M	2.51M	3.47M	3.54M	4.20M	5.24M	7.07M	7.38M	7.85M	8.74M	7.43M	7.42M
Operating Income	-1.73M	-1.89M	-2.02M	-1.61M	-1.41M	-1.13M	-1.01M	-1.32M	-689.47K	-1.02M	-833.61K	-620.64K	-1.31M	-647.78K	-1.12M	-2.12M	-2.67M	-1.86M	-2.02M	-2.39M	-2.80M	-3.27M	-6.37M	-4.39M	-4.05M	-3.33M	-1.96M	-3.05M	-2.48M	-1.98M	931.00K	-531.00K	-1.29M	1.65M	1.48M	601.00K	1.44M	903.00K	-1.12M	-280.00K
Net Income	-818.33K	-4.44M	-2.56M	-1.69M	-1.49M	-1.16M	-1.52M	-1.03M	-1.72M	-1.12M	-1.14M	-493.53K	-1.42M	-851.33K	-5.86M	-2.89M	-825.14K	-2.20M	-2.73M	-2.75M	-3.00M	-3.63M	-12.64M	-4.94M	-8.62M	-4.25M	-5.10M	1.64M	-1.14M	-13.08M	-7.26M	-23.70M	-4.80M	6.19M	-21.16M	-6.12M	551.00K	9.69M	-1.44M	-682.00K
Diluted EPS	-0.04	-0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.01	-0.01	-0.03	-0.01	-0.02	-0.01	-0.01	0.00	0.00	-0.02	-0.01	-9.95	0.00	0.00	-6.65	-0.72	-0.04	0.39	-0.17	-0.08
R&D Expense	624.53K	775.72K	764.85K	1.01M	708.30K	634.62K	456.79K	569.13K	309.95K	476.17K	266.47K	260.34K	437.91K	266.84K	238.48K	328.75K	622.15K	261.00K	307.27K	299.90K	287.00K	265.00K	432.00K	354.00K	272.00K	297.00K	166.00K	171.00K	157.00K	131.00K	139.00K	165.00K	163.00K	195.00K	161.00K	208.00K	194.00K	345.00K	660.00K	628.00K

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	728.45K	802.57K	769.22K	800.03K	847.37K	965.50K	1.38M	738.53K	1.85M	1.03M	3.63M	11.38M	15.51M	19.25M	32.33M	44.05M
Gross Profit	478.12K	540.68K	548.96K	610.24K	627.39K	680.54K	-	496.56K	1.16M	489.81K	2.90M	8.02M	12.41M	14.36M	24.55M	33.97M
Operating Income	-11.81M	-8.81M	-6.06M	-5.98M	-5.96M	-4.44M	-3.32M	-3.82M	-7.18M	-8.79M	-25.20M	-14.14M	-8.95M	-540.00K	3.85M	4.95M
Net Income	-14.92M	-10.24M	-6.40M	-11.30M	-5.97M	-4.81M	-6.44M	-5.54M	-11.63M	-10.43M	-30.94M	-27.26M	-10.29M	-25.81M	-33.08M	11.81M
Diluted EPS	-1.15	-0.52	-0.30	-	-	-	-	-	-	-0.05	-0.08	-0.05	-0.02	-12.19	-7.41	0.41
R&D Expense	3.88M	2.73M	1.76M	2.30M	3.00M	2.17M	1.13M	1.29M	981.65K	1.18M	1.25M	1.10M	567.00K	579.00K	673.00K	1.35M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Dec 2023	Jan 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Assets	-	3.03M	6.17M	1.85M	1.59M	4.67M	958.36K	1.00M	1.28M	1.18M	3.38M	23.03M	18.62M	17.01M	17.84M	18.78M	19.87M	22.42M	-	30.12M	-	-	-	37.34M
Total Equity	-	-10.52M	-1.54M	-6.52M	-6.13M	-1.55M	-5.88M	-6.91M	-9.88M	-15.36M	-10.06M	-13.72M	-38.96M	-38.07M	-35.53M	-35.31M	-41.01M	-44.55M	-44.55M	-15.79M	-20.81M	-18.80M	-7.59M	1.62M
Cash & Equivalents	1.79M	417.46K	3.91M	70.33K	182.31K	3.55M	152.93K	133.57K	730.18K	364.55K	1.76M	2.44M	619.00K	313.00K	1.48M	1.11M	1.15M	1.80M	-	10.24M	-	-	-	11.96M
Long Term Debt	-	-	-	5.37M	-	-	-	5.37M	-	-	-	143.00K	875.00K	-	-	-	-	-	-	-	-	-	-	16.14M
Total Liabilities	-	13.55M	7.70M	8.37M	7.72M	6.22M	6.84M	7.92M	11.16M	16.53M	13.45M	36.74M	57.58M	55.08M	53.38M	54.09M	60.88M	65.59M	66.96M	45.91M	51.67M	51.84M	43.19M	35.72M
Current Liabilities	-	8.17M	2.32M	2.99M	2.34M	6.22M	1.49M	7.92M	11.16M	16.49M	12.42M	36.17M	56.26M	53.91M	52.25M	53.59M	60.22M	64.75M	-	45.42M	50.78M	50.42M	23.98M	17.85M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-5.87M	-8.83M	-4.29M	-3.92M	-6.68M	-3.47M	-3.20M	-1.53M	-3.62M	-6.41M	-12.72M	-	-17.17M	-4.54M	2.46M	3.88M
Investing Cash Flow	7.00K	-42.30K	-2.01K	7.50K	-8.86K	100.00K	-8.77K	0	-42.89K	-53.94K	-20.05M	-	332.00K	21.00K	-490.00K	3.43M
Financing Cash Flow	4.50M	12.37M	450.42K	4.04M	10.07M	-	3.21M	2.12M	3.32M	7.86M	33.45M	-	17.38M	5.21M	6.35M	-5.59M
Capital Expenditure	-	-42.30K	-2.01K	-	-8.86K	-	-10.36K	-0	-42.89K	-53.94K	-53.00K	-529.00K	-	-	-490.00K	-1.94M
Free Cash Flow	-	-8.87M	-4.29M	-	-6.69M	-	-3.21M	-1.53M	-3.66M	-6.46M	-12.77M	-	-17.17M	-4.54M	1.97M	1.93M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	547.00K	694.00K	8.32M	1.72M

Ratios (Annual)

Figures in %.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	65.6%	67.4%	71.4%	76.3%	74.0%	70.5%	-	67.2%	62.5%	47.6%	79.8%	70.5%	80.0%	74.6%	75.9%	77.1%
Operating Margin %	-1,620.9%	-1,097.6%	-788.1%	-747.0%	-703.8%	-459.6%	-241.0%	-517.8%	-388.1%	-854.9%	-694.6%	-124.2%	-57.7%	-2.8%	11.9%	11.2%
Net Margin %	-2,048.5%	-1,275.7%	-832.2%	-1,412.4%	-705.0%	-498.2%	-467.9%	-749.9%	-628.7%	-1,013.9%	-852.7%	-239.5%	-66.4%	-134.0%	-102.3%	26.8%
ROE %	141.9%	666.4%	98.2%	184.4%	385.1%	81.8%	93.2%	56.0%	75.7%	103.6%	225.5%	70.0%	25.1%	57.9%	209.5%	729.6%
ROCE %	229.6%	-229.1%	530.7%	791.4%	384.4%	837.8%	48.0%	38.7%	46.9%	97.4%	191.7%	37.6%	22.2%	1.3%	-25.1%	25.4%

Shareholding Pattern

Insiders

1.30%

Institutions

37.33%

Public Float

37.82%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Solas Capital Management, LLC	7.15%	610.97K	$3.43M
2	AWM Investment Company, Inc.	5.32%	454.55K	$2.55M
3	Praetorian PR LLC	4.62%	395.00K	$2.22M
4	Vanguard Capital Management LLC	4.13%	352.76K	$1.98M
5	Opaleye Management Inc.	3.58%	306.14K	$1.72M
6	UBS Group AG	3.00%	256.79K	$1.44M
7	Blackrock Inc.	1.87%	159.87K	$898.45K
8	Geode Capital Management, LLC	1.01%	86.10K	$483.87K
9	Citadel Advisors Llc	0.70%	59.47K	$334.24K
10	Vanguard Fiduciary Trust Co	0.50%	43.10K	$242.21K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SNWV

Google News Mon, 27 Apr 2026

How The SANUWAVE Health (SNWV) Story Is Shifting After The Latest Price Target Reset - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOa3h3X08xLWRWZi0zRnVPd1J2alJhUF9LNVB6bFVibTBvWFBQTGRVUHVSQnVfRzJhX3RhcjNORDhVa1ZncVFtTlItSWlMQkdKeGhJM1pSTnVxWXN1T1Z4NU1BOEJXS3NPNUVqMmdXTjUzbjRuTHZMVG1kc0E3blNoTWRZRDJuU29NVmpFMT…

Google News Fri, 02 Oct 2026

SNWV Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE5hV21sdHNGTWp0TUlGRXI4ZTNMZnk1SWtkMUt6dzhTNzc4RjZ3Zlh6Y1BzZnZ2NTlkRmU2V2ZET19uM1JTLVNPbmlwRVkwMG1RTC1GaUNxajcwQVAzcDE5ZVdSeURNczg3Q09Mbnp6UmZycjIzb05tVm5n?oc=5" target="_blank">SNW…

Google News Fri, 17 Jul 2026

What's Going on With SANUWAVE Health Stock on Friday? - Benzinga

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOXy1pTXFBa1ZFa2hLV3ItN3E4S1pkTy1IYVNpdlgxNl9QY3lqcUYtZXRPeWl5VVNvMW9mZ0N3NFYxcEV5Y3lqWXd5ckxrc1IzMTJjUGdSM3Zmc3VhTjNWang0bFdiWlJ3dW1URnRnNGU0MFdWdmgyZnlJZE9WXzZwd0hETlV6MUlteEV3ZE…

Google News Mon, 19 Oct 2026

(SNWV) and the Role of Price-Sensitive Allocations - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQdGxOQksybHZsdVNodGV1aWtVbmM2SHpyampYQlQwemFGb1BNWFdad0lIVTVqb0pUdGJ4bFJ6SDNmS1BHSWJKbHVpOC1DZ3gtMENPMGJDMElHNzBYUGZKNDJjTGdzanBRLW5oTXlDRXZxNXBIQS1ybDJKbG9xaWwzbnc5d0NydlRMQmxpSk…

Google News hu, 16 Jul 2026

Market Movers | Winners: CPHI, SOBR, ELVA | Losers: ILLR, SNTI, SNWV - Trefis

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNX3BrWlZmdGNpVHJWbEtYUDc0QmVsSWRGQVVoQmlPZksxSDgxRm50bkpxOG94di0xTXBqUjZ2dndzZGlEN0hTU3RIaDVoTTZsMnluR1QtaWZyNHhOdUhQVmc4OVo3V0tPeGFlTVJyd3JGdEdZeVZUbjh1bnlTbmZsTWZiMTZVaXpLZ3RhUW…

Google News ue, 12 May 2026

How The SANUWAVE Health (SNWV) Investment Story Is Shifting Around The US$43.50 Target - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNNlZxUmFFQjJldnJJdENwdEV0T2xoUGlVdzEwLWNLbVJ0eFZYVk93THdhSWJoZktOWUx4T05lTVpKMzBCQlRfOWpRN1otaEtndjZrMGo0Q2FxTDJyenNxRUdYRmFkYnpWNy1IekQ5MzZpSlcwcFY0WFNmWGhrcWx6eUpoWTkwMnk1aWoxWG…

SNWV — Frequently Asked Questions

What is the current share price of SANUWAVE Health, Inc. (SNWV)?

As of 2026-10-23 16:27 PDT, SANUWAVE Health, Inc. (SNWV) trades at $5.22 on NasdaqGM. Its 52-week range is $4.00 to $45.00.

What is the market capitalisation of SNWV?

SANUWAVE Health, Inc. (SNWV) has a market capitalisation of $44.90M on NasdaqGM.

What is the P/E ratio of SNWV?

SNWV trades at a trailing price-to-earnings (P/E) ratio of 6.44. The industry average P/E is 25.45. Its price-to-book (P/B) ratio is 14.04.

Is SNWV a good stock to buy?

This page provides a data-driven analysis of SANUWAVE Health, Inc. (SNWV), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

SANUWAVE Health, Inc. SNWV R2KPHARMA

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

How The SANUWAVE Health (SNWV) Story Is Shifting After The Latest Price Target Reset - Yahoo Finance

SNWV Forecast — Price Target — Prediction for 2027 - TradingView

What's Going on With SANUWAVE Health Stock on Friday? - Benzinga

(SNWV) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Market Movers | Winners: CPHI, SOBR, ELVA | Losers: ILLR, SNTI, SNWV - Trefis

How The SANUWAVE Health (SNWV) Investment Story Is Shifting Around The US$43.50 Target - Yahoo Finance

SNWV — Frequently Asked Questions

What is the current share price of SANUWAVE Health, Inc. (SNWV)?

What is the market capitalisation of SNWV?

What is the P/E ratio of SNWV?

Is SNWV a good stock to buy?

Explore More